In recent years, progress in nanotechnology provided new tools to treat cancer more
effectively. Advances in biomaterials tailored for drug delivery have the potential to …

Intrinsic shortcomings associated with conventional therapeutic strategies often compromise
treatment efficacy in clinical ophthalmology, prompting the rapid development of versatile …

MicroRNAs (miRNAs) are, small (roughly 19–25 nucleotides in length), conserved, non-
coding, single-stranded, and functional RNA molecules with the properties of gene …

Simple Summary According to the International Agency for Research on Cancer (IARC), in
2018, the global burden of cancer is expected to grow to 27.5 million new cancer cases by …

Cancer is a major healthcare burden and cause of death worldwide, with an estimated 19.3
million new cancer cases and 10 million cancer deaths globally only in 2020. While several …

Melanoma is the most aggressive form of skin cancer, characterized by life-threatening and
rapidly spreading progression. Traditional targeted therapy can alleviate tumors by …

Molecular biology studies of uveal melanoma have resulted in the development of novel
immunotherapy approaches including tebentafusp—a T cell–redirecting bispecific fusion …

Abstract Hypothesis Superparamagnetic Mn x Fe 3-x O 4 nanoparticles are promising
materials for applications in biomedicine and other fields. Small variations in the Mn/Fe ratio …

Simple Summary Human uveal melanoma (UM) is the most common primary intraocular
tumor with high metastatic risk in adults. Currently, no effective treatment is available for …

Epithelial-mesenchymal transition (EMT) has emerged as a key regulator of cell invasion
and metastasis in cancers. Besides the acquisition of migratory/invasive abilities, the EMT …